With effect from November 30, 2023, the subscription rights in Annexin Pharmaceuticals AB will be traded on First North Growth Market. Trading will continue up until and including December 11, 2023. Instrument: Subscription rights Short name: ANNX TR Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021148699 Order book ID: 313318 Market Segment: First North STO Tick Size: MiFID II tick size table With effect from November 30, 2023, the paid subscription shares in Annexin Pharmaceuticals AB will be traded on First North Growth Market. Trading will continue until further notice. Instrument: Paid subscription shares Short name: ANNX BTA Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0021148707 Order book ID: 313319 Market Segment: First North STO Tick Size: MiFID II tick size table For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com Nasdaq Stockholm AB
© 2023 GlobeNewswire
